CPT1A-mediated Fat Oxidation, Mechanisms, and Therapeutic Potential.
Level 5 - mechanism / opinion, no new human data
Narrative review synthesizing mechanistic biology without systematic search criteria.
PubMed 31900483 · doi:10.1210/endocr/bqz046
What was done
This narrative review synthesizes literature on carnitine palmitoyltransferase 1A (CPT1A), the rate-limiting enzyme facilitating mitochondrial fatty acid oxidation (FAO) by converting acyl-CoAs to acyl-carnitines. It summarizes the multi-layered regulation of CPT1A (genetic, epigenetic, physiological, and nutritional) and its roles in inborn errors of metabolism, circumpolar environmental adaptations, metabolic disease, and cancer.
What was found
The abstract reports descriptive findings without quantitative effect estimates: over 15 genetic FAO defects have been described, more than two dozen enzymes and transport proteins participate in FAO, and CPT1A is identified as a critical regulatory node across multiple disease states and environmental adaptations.
Why it matters
It consolidates understanding of how mitochondrial fatty acid oxidation is controlled at the molecular level, highlighting CPT1A as a candidate target for therapeutic interventions in oncology and metabolic disorders.
Limits
As a narrative review, it presents no primary clinical data, quantitative meta-analyses, or statistical tests in the abstract. Methodological details regarding literature search and selection were not reported.
Cited by
- supports Carnitine palmitoyltransferase (CPT) acts as the critical gatekeeper enzyme transporting fatty acids into the mitochondria for oxidation.